Agile Therapeutics adds Seth H. Z. Fischer to its board
Mr. Fischer will serve on Agile's Compensation and Nominating & Corporate Governance Committees.
Mr. Fischer has more than three decades of healthcare experience in the pharmaceutical and medical device industry. He currently serves as Chief Executive Officer and a Director of Vivus, Inc., a publicly traded biopharmaceutical company.
Mr. Fischer also serves as a member of the Board of Directors of BioSig Technologies, Inc., and is an advisor to MedHab, LLC. He has served in positions of increasing responsibility with Johnson & Johnson from 1983 until his retirement in 2012.
Most recently, Mr. Fischer served as Company Group Chairman Johnson & Johnson and Worldwide Franchise Chairman, Cordis Corporation from 2008 to 2012, and as Company Group Chairman, North America Pharmaceuticals from 2004 to 2007, which included responsibilities for Ortho-McNeil Pharmaceuticals, Janssen and Scios.
Prior to that, Mr. Fischer served as President of Ortho-McNeil Pharmaceuticals from 2000 to 2004.
His operating responsibilities encompassed the commercialization of products in multiple therapeutic categories including Topamax for epilepsy and migraine and products in the analgesic, anti-infective, cardiovascular, neurologic, psychiatric and women's health areas, including ORTHO EVRA, one of the most successful contraceptive launches in the U.S and the first ever contraceptive patch.
He earned a Bachelor of General Studies from Ohio University and served as a captain in the U.S. Air Force.
The Company also announced that Karen Hong, Ph.D., who has served as a member of the Company's Board of Directors since 2006, has stepped down from her role as a director of Agile effective July 28, 2016, in order to devote her full time and efforts to her other commitments. ■